Clinical Significance of Therapeutic Drug Level Monitoring for Mycophenolate in Patients With Extrarenal Systemic Lupus Erythematosus—A Systematic Review and Meta‐Analysis

Documenti analoghi

• Toward Optimal Dosing in Systemic Lupus Erythematosus: The Case for Hydroxychloroquine Blood Level Monitoring
  di: Stephen Balevic, et al.
  Pubblicazione: (2026)
• Addressing Economic Insecurities Can Improve Patient‐Reported Outcomes in Lupus
  di: Jay Patel, et al.
  Pubblicazione: (2026)
• Development of the American College of Rheumatology Patient‐Reported Outcome Quality Measures for Systemic Lupus Erythematosus
  di: Patricia P. Katz, et al.
  Pubblicazione: (2024)
• Multiplicative Impact of Adverse Social Determinants of Health on Outcomes in Lupus Nephritis: A Meta‐analysis and Systematic Review
  di: Shivani Garg, et al.
  Pubblicazione: (2024)
• Systematic Review of Inequitable Population Representation in Systemic Lupus Erythematosus Clinical Trials
  di: Seth Sims, et al.
  Pubblicazione: (2025)